4/A

FORM 4/A SUBMISSION

Company: LIGAND PHARMACEUTICALS INC
Filed: August 28, 2020
Period of Report: August 25, 2020
Accession Number: 0000899243-20-023644

View Document ↗ View on SEC.gov ↗